Table 2.
Comparison of antibiotic consumption two years before and after the initiation of NARP*
| Restricted Antibiotics | Antibiotic consumption (grams) | % difference | |
|---|---|---|---|
| 2001+2002 | 2003+2004 | ||
| Meropenem | 113362 | 85236 | -24.8 |
| Imipenem | 50532 | 45935.2 | -9.1 |
| Ceftazidim | 60074 | 38129 | -36.5 |
| Ceftriaxone | 300955 | 190281 | -36.8 |
| PIP-TAZO* | 270594 | 417114 | +54.1 |
| Cefepime | 100588 | 121799 | +21.1 |
| Vancomycin | 113362 | 85236 | -17.8 |
| Teicoplanin | 50532 | 45935.2 | -1.4 |
| Total | 60074 | 38129 | -11.3 |
*nationwide antibiotic restriction program, **piperacillin-tazobactam